2007

• Gilson AM. Interpreting changes in state laws and regulations governing the use of controlled substances to treat pain. Advances in Pain Management. 2007;1:60-66.
• Gilson AM, Joranson DE, Maurer MA. Improving state pain policies: Recent progress and continuing opportunities. CA: A Cancer Journal for Clinicians. 2007;57:341-353.
• Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns. J Pain Palliat Care Pharmacother. 2007;21:21-24.
• Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. Journal of Pain. 2007;8:682-691.
• Joranson DE, Gilson AM. A much-needed window on opioid diversion (Editorial). Pain Med 2007;8(2):128-129.
• Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (Fourth edition). 2007.
• Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card (Third edition). 2007.

• Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (Third edition). Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2006.
• Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card (Second edition). Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2006.
• Joranson DE, Gilson AM. Wanted: A public health approach to prescription opioid abuse and diversion (Editorial). Pharmacoepidemiology and Drug Safety. 2006;15:632-634.
• Maurer MA, Gilson AM, Joranson DE. Federal and state policies at the interface of pain and addiction. In: Smith H, Passik S, eds. Pain and Chemical Dependency. New York: Oxford University Press; 2006.

• Joranson DE, Gilson AM. Drug crime is a source of abused pain medications in the United States. J Pain Symptom Manage. 2005; 30(4):299-301.
• Gilson AM, Maurer MA, Joranson DE. State policy affecting pain management: Recent improvements and the positive impact of regulatory health policies. Health Policy. 2005; 74(2):192-204.
• Gilson AM, Joranson DE, Maurer MA, Ryan KM, Garthwaite JP. Progress to achieve balanced state policy relevant to pain management and palliative care: 2000-2003. J Pain Palliat Care Pharmacother. 2005; 19(1):7-20.

• Drug Enforcement Administration, Last Acts, Pain & Policy Studies Group. Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals and Law Enforcement Personnel. Washington, DC: Drug Enforcement Administration; 2004.
• Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004; 28(2):176-188.

• Joranson DE, Gilson AM. Legal and regulatory issues in the management of pain. In: Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB, editors. Principles of addiction medicine. Chevy Chase, MD: American Society of Addiction Medicine, Inc., 2003: 1465-1474.
• Joranson DE, Payne R. Will my pain be managed? In: Edmondson WAD, editor. Improving End-of-Life Care: The Role of Attorneys General. Washington, DC: National Association of Attorneys General, 2003: 27-34.
• Joranson DE, Gilson AM, Ryan KM, Maurer MA. Availability of opioid analgesics for cancer pain relief in children. In: McGrath PJ, Finley GA, eds. Pediatric Pain: Biological and Social Context. Seattle, WA: IASP Press; 2003:201-216.
• Joranson DE, Gilson AM, Ryan KM, Maurer MA, Jorenby JP, Kline JF. Achieving Balance in State Pain Policy: A Progress Report Card. University of Wisconsin Comprehensive Cancer Center. Madison, Wisconsin, September 2003.
• Joranson DE, Gilson AM, Ryan KM, Maurer MA, Jorenby JP. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation, Second Edition. University of Wisconsin Comprehensive Cancer Center. Madison, Wisconsin, 2003.
• Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM. Definitions related to the medical use of opioids: Evolution towards universal agreement. J Pain Symptom Manage. 2003; 26(1):655-667.
• Gilson AM, Joranson DE, Maurer MA. Improving state medical board pain policies: Influence of a Model. Journal of Law, Medicine & Ethics. 2003; 31(1):119-129.

• Joranson DE, Gilson AM, Nischik JA. North Carolina, pain management and end-of-life care: Communicating the policy. Fed Bull, J Med Licen & Disc. 2002; 88(3):116-119.
• Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002; 18(4 suppl):S91-S98.
• Dahl JL, Bennett ME, Bromley MD, Joranson DE. Success of the state pain initiatives. Cancer Pract. 2002;10(Suppl. 1):S9-S13.
• Joranson DE, Carrow GM, Ryan KM, et al. Pain management and prescription monitoring. Journal of Pain and Symptom Management. 2002; 23(3):231-238.
• Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: A Decade of Change.  Journal of Pain and Symptom Management. 2002;23(2):138-147.
• Joranson DE, Maurer MA, Gilson AM, Ryan KM.  2001 Annual review of state pain policies: A question of Balance.  Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin; February 2002.

• Gilson AM, Joranson DE.  Controlled substances and pain management: Changes in knowledge and attitudes of state medical regulators.  Journal of Pain and Symptom Management.  2001;21(3):227-237.
• Joranson DE, Gilson AM.  Pharmacists’ knowledge and attitudes about opioid pain medications in relation to federal and state policy.  Journal of the American Pharmaceutical Association.  2001;41(2):213-220.
• Joranson DE, Maurer MA, Gilson AM, Ryan KM, Nischik JA.  Annual review of state pain policies, 2000.  Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin; February 2001.

• Gilson AM, Joranson DE, Ryan KM.  Editorial: Medical use and abuse of opioids.  Journal of Pharmaceutical Care in Pain & Symptom Control.  2000;8(4):1-4.
• Gilson AM, Ryan KM, Maurer MA.  A bibliography of recent pharmaceutical care articles on pain management and end-of-life care issues.  Journal of Pharmaceutical Care in Pain & Symptom Control.  2000;8(4):49-56.
• Joranson DE, Ryan KM, Gilson AM, Dahl JL.  Trends in medical use and abuse of opioid analgesics.  Journal of the American Medical Association.  2000;283(13):1710-1714.
• Joranson DE, Ryan KM, Gilson AM, Dahl JL. Letter to the editor: Reporting drug abuse in the emergency department.  Journal of the American Medical Association.  2000;284(5):564.
• Joranson DE, Gilson AM, Ryan KM, Maurer MA, Nischik JA, Nelson JM.   Achieving balance in federal and state pain policy: A guide to evaluation.  The Pain & Policy Studies Group, University of Wisconsin Comprehensive Care Center.  Madison, Wisconsin; July 2000.
  

1998

• Joranson DE, Gilson AM.  Controlled substances and pain management: A new focus for state medical boards.  Federation Bulletin.  1998;85(2):78-83.
• Pain & Policy Studies Group.  Resource guide: Information about regulatory issues in pain management.  Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin; 1998.

1997

• Joranson DE.  Is methadone maintenance the last resort for some chronic pain patients? American Pain Society Bulletin. 1997;7(5):1,4-5.
• Joranson DE, Gilson AM. State intractable pain policy: Current status. American Pain Society Bulletin. 1997;7(2):7-9.

• Joranson DE, Gilson AM. Improving pain management through policy making and education for medical regulators. Journal of Law, Medicine and Ethics.  1996;24:344-347.
• Joranson DE. State pain commissions: new vehicles for progress? American Pain Society Bulletin. 1996;6(1):7-9.

• Joranson DE. State medical board guidelines for intractable pain treatment. American Pain Society Bulletin. 1995;5(3):1-5.
• Joranson DE. Intractable pain treatment laws and regulations. American Pain Society Bulletin. 1995;5(2):1-3,15-17.
• Angarola RT, Joranson DE. Off-label uses of prescription drugs in pain management. American Pain Society Bulletin. 1995;5(1):14-15.

• Joranson DE, Gilson AM. Policy issues and imperatives in the use of opioids to treat pain in substance abusers. Journal of Law, Medicine and Ethics.  1994;22(3):5-13.
• Joranson DE. Are health care reimbursement policies a barrier to acute and cancer pain management? Journal of Pain and Symptom Management.  1994;9(4):244-253.
• Joranson DE, Gilson AM. Controlled substances, medical practice and the law. In: Schwartz HI. Psychiatric Practice Under Fire: The Influence of Government, the Media and Special Interests on Somatic Therapies. Washington, DC: American Psychiatric Press, Inc. 1994;173-194.
• Angarola RT, Joranson DE. Healthcare reimbursement policies: Do they block acute and cancer pain management?  American Pain Society Bulletin. 1994;4(5):7-9.
• Angarola RT, Joranson DE. California sponsors pain summit; Maryland fends off new regulations. American Pain Society Bulletin. 1994;4(3):11-12.
• Angarola RT, Joranson DE. Recent developments in pain management and regulation. American Pain Society Bulletin. 1994;4(1):9-11.

• Joranson DE. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. In: Cooper JR et al. Evaluation of the Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care: Possible Implications for Future Research. National Institute on Drug Abuse Technical Research Monograph 131. Rockville, MD: NIDA, 1993.
• Joranson DE. Availability of opioids for cancer pain: Recent trends, assessment of system barriers, new WHO guidelines, and the risk of diversion. Journal of Pain and Symptom Management. 1993;8:353-360.
• Angarola RT, Joranson DE. Wins and losses in pain control. American Pain Society Bulletin. 1993;3(4):8-9.
• Angarola RT, Joranson DE. More federal drug control initiatives: Are they warranted? Will they consider the patient? American Pain Society Bulletin. 1993;3(2):1-2,8-9.
• Joranson DE. Regulatory influence on pain management: real or imagined? Journal of Pharmaceutical Care in Pain and Symptom Control.  1993;1(1):113-118.

• Dahl JL, Joranson DE. Cancer pain: The U.S. responds. Palliative Medicine. 1992;6:94-97.
• Joranson DE, Cleeland CS, Weissman DE, Gilson AM. Opioids for chronic cancer and non-cancer pain: A survey of state medical board members. Federation Bulletin: The Journal of Medical Licensure and Discipline. 1992;79(4):15-49.
• Angarola RT, Joranson DE. Single-copy serialized prescriptions: Old regulation in new clothing? American Pain Society Bulletin. 1992;2(4):14-15.
• Angarola RT, Joranson DE. State controlled substances laws and pain control. American Pain Society Bulletin. 1992;2(3):10-11,15.
• Angarola RT, Joranson DE. Pain and euthanasia: The need for alternatives. American Pain Society Bulletin. 1992;2(2):10,17.
• Angarola RT, Joranson DE. Legislating proper pain management. American Pain Society Bulletin. 1992;2(1):13-15.

• Joranson DE. Cancer pain and regulation of opioids: Balancing drug control and availability. Pharmacy Law Annual. 1991;3-13.
• Weissman DE, Joranson DE, Hopwood MB. Wisconsin physicians' knowledge and attitudes about opioid analgesic regulations. Wisconsin Medical Journal. 1991;December:671-675.

• Joranson DE. Federal and state regulation of opioids. Journal of Pain and Symptom Management. 1990;5(Suppl):12-23.
• Joranson DE. A new drug law for the states: An opportunity to affirm the role of opioids in cancer pain relief. Journal of Pain and Symptom Management. 1990;5(Suppl):333-336.
• Weissman DE, Dahl JL, Joranson DE. Oral morphine for the treatment of cancer pain. Cancer: Principles and Practice in Oncology Update Series. 1990;4(6):1-8.
• Joranson DE. Why is a balanced policy important, and do we have it now? Balancing the Response to Prescription Drug Abuse, Report of a National Symposium on Medicine and Public Policy, American Medical Association, Department of Substance Abuse, Chicago, 1990:1-6.
• Dahl JL, Joranson DE. The Wisconsin Cancer Pain Initiative. In: Foley KM, Bonica JJ, Ventafridda V. Advances in Pain Research and Therapy, Volume 16. New York: Raven Press, 1990:499-503.

• Joranson DE, Dahl JL. Achieving balance in drug policy: the Wisconsin model. In: Hill CS Jr., Fields WS. Advances in Pain Research and Therapy, Volume 11. New York: Raven Press, 1989:197-204.
• Dahl JL, Joranson DE, Weissman DE. The Wisconsin Cancer Pain Initiative: a progress report. American Journal of Hospice Care 1989;6(6):39-43.
• Joranson DE. Responding to prescription drug abuse. Cancer Pain Release 1989;3(1):1.

• Dahl JL, Joranson DE, Engber D, Dosch J. A report on the Wisconsin Cancer Pain Initiative. Journal of Pain and Symptom Management. 1988;3(Suppl):1-20.

• Joranson DE, Dahl JL, Engber D. Wisconsin initiative for improving cancer pain management: progress reports. Journal of Pain and Symptom Management. 1987;2:111-114.

• Treffert DA, Joranson DE. Delta 9 Tetrahydrocannabinol and therapeutic research legislation for cancer patients. [Abstract] JAMA 1983;249:1469-1472.

2007

• Joranson DE, Ryan KM. Ensuring opioid availability: Methods and resources. J Pain Symptom Manage. 2007; 33(5):527-532.
• Ryan KM. The Pain & Policy Studies Group international program. J Pain Palliat Care Pharmacother. 2007;21:35-37.
• Rajagopal MR, Joranson DE. India: Opioid availability - An update. J Pain Symptom Manage. 2007;33:615-622.
• Pain & Policy Studies Group. Improving availability of essential pain medicines for cancer and HIV/AIDS pain relief: Report for 2006. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care, 2007.

• Mosoiu D, Ryan KM, Joranson DE, Garthwaite JP. Reforming drug control policy for palliative care in Romania. Lancet. 2006;367:2110-2117.
• Pain & Policy Studies Group. Improving availability of essential pain medicines for cancer and HIV/AIDS pain relief: Report for 2005. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care, 2006.

• Joranson DE, Gilson AM, Maurer MA. Improving opioid availability. Indian J Palliat Care. 2005;11:60-61.
• Pain & Policy Studies Group. Improving cancer pain relief in the world: Report for 2004. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care, 2005.

• Pain & Policy Studies Group. Improving Cancer Pain Relief in the World: Report for 2003. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; 2004.

• Pain & Policy Studies Group. Improving Cancer Pain Relief in the World: Report for 2002. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; 2003.
• Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care. 2003; 12(1):28-34.
• Joranson DE. Improving availability of opioid pain medications: Testing the principle of balance in Latin America. Innovations in End-of-Life Care. 2003; 5(1).

• Pain & Policy Studies Group. Improving Cancer Pain Relief in the World: Report for 2001. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; 2002.
• Joranson DE, Rajagopal MR, Gilson AM. Improving access to opioid analgesics for palliative care in India. Journal of Pain and Symptom Management. 2002; 24(2):152-159.

• Pain & Policy Studies Group. Improving Cancer Pain Relief in the World: 2000. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; 2001.
• Rajagopal MR, Joranson DE, Gilson AM.  Medical use, misuse and diversion of opioid analgesics in India.  Lancet. 2001;358:139-143.

• Pain & Policy Studies Group. Improving Cancer Pain Relief in the World: 1997-1999, a Report on Three Years of Work. Madison, Wisconsin, USA: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; 2000.

• Joranson DE. Obtaining oral morphine in India: Guidelines and a proposal to simplify the narcotic regulations. Indian Journal of Palliative Care. 1998; 4(2):5-16.
• Joranson DE.  Opioid availability in Africa.  Journal of Pharmaceutical Care in Pain and Symptom Control. 1998;6(4):1-4.

• De Lima L, Bruera E, Joranson DE, et. al. Opioid availability in Latin America: The Santo Domingo Report-Progress since the Declaration of Florianopolis. Journal of Pain and Symptom Management. 1997;13(4):213-219.
• Joranson DE, Gilson AM. U.N. Agency: Global action needed to improve opioid availability. American Pain Society Bulletin. 1997;7(2):10-11.

• International Narcotics Control Board.  Availability of opiates for medical needs:  Report of the International Narcotics Control Board for 1995. New York, NY: INCB. 1996.
• Joranson DE. New international efforts to ensure availability of opioids for medical purposes. Journal of Pain and Symptom Management. 1996;12(2):85-86.
• Pain & Policy Studies Group. First Annual Report: 1996. Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin; 1996.
• Zhang H, Gu W, Joranson DE, Cleeland CS. People's Republic of China: Status of cancer pain and palliative care. Journal of Pain and Symptom Management. 1996;12(2):124-126.

• Angarola RT, Joranson DE. International efforts under way to provide adequate medication for pain control. American Pain Society Bulletin. 1995;5(6):9-10,23.
• Joranson DE. Fears of dependence of morphine: the background. In: Takeda, F.  Morphine: Its Indication and Limitation in Cancer Pain Management. Tokyo, Japan: Shinko-Koeki, Ltd. 1995;134-141.
• Joranson DE, Cai ZJ, Gilson AM. Barriers to opioid availability in China. Bulletin on Drug Dependence. 1995;4(2).
• Stjernsward J, Bruera E, Joranson DE, Allende S, et al.  Opioid availability in Latin America: The Declaration of Florianopolis. Journal of Pain and Symptom Management. 1995;10(3):233-236.
• Stjernsward J, Joranson DE. Opioid availability and cancer pain: An unnecessary tragedy. Supportive Care in Cancer. 1995;3:157-158.

• Joranson DE. Global opioid consumption: Trends, barriers, and diversion. International Association for the Study of Pain Newsletter. 1994;September/October:4-5.
• Joranson DE. Prescribing for cancer pain (in the Netherlands): Reflections on progress and directions. Journal of Pharmaceutical Care in Pain & Symptom Control. 1994;2(2):1-4.

• Joranson DE. Fear of addiction is an impediment to cancer pain relief: A proposal to the World Health Organization Programme on Substance Abuse. Symptom Control in Cancer Patients. 1993;5:52-58.
• Joranson DE.  Availability of opioids for cancer pain: Recent trends, assessment of system barriers, new WHO guidelines, and the risk of diversion.  Journal of Pain and Symptom Management. 1993;8:353-360.

• Joranson DE. Progress and issues in opioid availability. International Association for the Study of Pain Newsletter. 1992;July/August:9-10.

• Dahl JL, Joranson DE. Relieving cancer pain. World Health. 1987;November:28-29.

Back to top of page

• Pain & Policy Studies Group. Availability of Opioid Analgesics In the World and Asia With a special focus on: Indonesia, Philippines, Thailand. Workshop on Assuring Availability and Accessibility Of Opioid Analgesics for Pain and Palliative Care. Boracay Island, Philippines; April 19-21, 2008 (Monograph).
• Pain & Policy Studies Group. Descripción de la Disponibilidad de Opioides in América Latina. Preparado para el IV Congreso de la Asociación Latinoamericana de Cuidados Paliativos, I Congreso de la Sociedad Peruana de Cuidados Paliativos. Lima, Peru; Marzo 27-29 de 2008 (Monograph).
• Pain & Policy Studies Group. Availability of morphine and pethidine in the world and Africa with a special focus on: Botswana, Lesotho, Mozambique, Namibia, Swaziland. Prepared for Advocacy for Palliative Care in Africa: A Focus on Essential Pain Medication Accessibility. Windhoek, Namibia; February 27-29, 2008 (Monograph).

• Pain & Policy Studies Group. Availability of morphine and pethidine in the world and Africa with a special focus on: Cameroon, Cote d'Ivoire, Ghana, Nigeria, Sierra Leone, The Gambia. Prepared for Advocacy for Palliative Care in Africa: A Focus on Essential Pain Medication Accessibility; 9-11 May 2007 (Monograph).

• Pain & Policy Studies Group. The Single Convention on Narcotic Drugs - Implementation in Eight Countries: Argentina, Colombia, Nigeria, Panama, Serbia, Sierra Leone, Uganda, Vietnam. Prepared for the International Pain Policy Fellowship; 23-27 October 2006 (Monograph).
• Pain & Policy Studies Group. Availability of Morphine and Pethidine in the World and Africa, With a special focus on: Botswana, Ethiopia, Kenya, Malawi, Nigeria, Rwanda, Tanzania, Zambia. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for Advocacy for Palliative Care in Africa: A Focus on Essential Pain Medication Accessibility. Entebbe, Uganda; June 27-29, 2006 (Monograph).
• Pain & Policy Studies Group. Descripción De La Disponibilidad De Opioides in América Latina. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Preparado para el III Congreso de la Asociación Latinoamericana de Cuidados Paliativos, IX Curso Latinoamericano de Medicina y Cuidados Paliativos. Isla Margarita, Venezuela; Marzo 22-25 de 2006 (Monograph).

• Pain & Policy Studies Group. Opioid Availability: Eastern Europe and Central Eurasia. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for Palliative Care in Cancer; Budapest, Hungary; 4-7 September 2005 (Monograph).
• Pain & Policy Studies Group. The Study Programme on Drug Abuse and Narcotics Control. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA; June 2005. (Monograph)
• Pain & Policy Studies Group. Selected Resources About Opioid Availability. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for the 2nd Global Summit of National Hospice and Palliative Care Associations; Seoul, Korea; 15-16 March 2005 (Monograph).

• Pain & Policy Studies Group. Overview of opioid availability. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for the Open Society Institute Seminar Series, Palliative Care for HIV/AIDS Patients; Kiev, Ukraine; February 2004 (Monograph).
• Pain & Policy Studies Group. Availability of Opioid Analgesics in Romania, Europe, and the World 2004 (2001 data). (Monograph). 2004. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Pain & Policy Studies Group. Improving access to opioid analgesics for pain relief in the Middle East. Prepared for the the United States National Cancer Institute, Middle East Cancer Consortium (MECC), Palliative Care in the Middle East; Larnaca, Cyprus; February 2004 (Monograph). 2004. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Pain & Policy Studies Group. Availability of opioid analgesics for palliative care in India. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for meeting in Hyderabad, India 'Opioid Availability in Palliative Care' in March 2004 (Monograph).
• Pain & Policy Studies Group. Descripción de la Disponibilidad de Opioides in América Latina. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Preparado para El II Congreso de la Asociación Latinoamericana de Cuidados Paliativos VIII Curso Latinoamericano de Medicina y Cuidados Paliativos. Montevideo, Uruguay 30 de marzo al 2 de abril de 2004 (Monograph).
• Pain & Policy Studies Group. Opioid Availability in the World. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Assuring availability of opioid analgesics for palliative care; Geneva, Switzerland; 1-3 September 2004 (Monograph).

• Pain & Policy Studies Group. Availablity of opioid analgesics in Romania, Europe, and the world. (Monograph). 2003. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Pain & Policy Studies Group. Opioid analgesics (narcotics) in Asia: Trends, resources, recommendations. Prepared for the 18th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; July 2003 (Monograph). 2003. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Pain & Policy Studies Group. Making Opioid Pain Medications Avaialable to Patients Is an Essential Part of Cancer Control. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for the WHO Consultation on Strategies to Improve and Strengthen Cancer Control Programmes in Europe; Geneva, Switzerland; 25-28 November 2003 (Monograph).

• Pain & Policy Studies Group. Opioid Analgesics: Trends, Guidelines, Resources. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care. Madison, Wisconsin, USA. Prepared for the International Association for the Study of Pain 10th World Congress on Pain; San Diego, California; August 17-22, 2002 (Monograph).
• Pain & Policy Studies Group. Availability of Opioid Analgesics in Africa and the World. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care. Madison, Wisconsin, USA Prepared for the WHO meeting, "A Community Health Approach to Palliative Care for HIV/AIDS and Cancer Patients in Africa"; Gaborone, Botswana; July 9-12, 2002 (Monograph).
• Pain & Policy Studies Group.  Availability of opioid analgesics in Asia: Consumption trends, resources, recommendations.  University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA.  Prepared for the 17th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; June 26, 2002 (Monograph). 
• Pain & Policy Studies Group.  Disponibilidad de analgésicos opioides en las Américas y en el mundo.  University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA.  Preparado para: I Congreso de la Asociacion Latinoamericana de Cuidados Paliativos, VII curso Latinoamericano de medicina y cuidados paliativos; Guadalajara, Mexico; 20-22 marzo de 2002 (Monograph). [Español]
• Pain & Policy Studies Group. Availability of opioid analgesics in Latin America and the world. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for: Ist Congress of the Latin American Association of Palliative Care, 7th Latin American Course on medicine and palliative care; Guadalajara, Mexico; 20-22 March 2002 (Monograph). [English]
• Pain & Policy Studies Group.  Availability of opioid analgesics in Eastern Europe and the world.  University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA.  Prepared for the Workshop on Assuring Availability of Opioid Analgesics for Palliative Care; Budapest, Hungary; February 25-27, 2002 (Monograph). 

• Joranson DE, Gilson AM, Nischik JA, & Maurer MA. Fact Sheet: Morphine for Cancer Pain in India. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care. Madison, Wisconsin, USA 2001 (Monograph).
• Joranson DE. Availability of Opioid Analgesics in Asia: Progress, Problems, Recommendations. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care. Madison, Wisconsin, USA. Prepared for the 16th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; July 5, 2001 (Monograph).

• Joranson DE, Gilson AM, Nelson JM.  Fact sheet: Morphine for cancer pain in India.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the 7th International Conference of the Indian Association of Palliative Care in Bangalore, India; February 2000.
• Joranson DE, Nischik JA, Gilson AM, Nelson JM, Maurer MA.  Consumo de Analgésicos Opioides en el Mundo y la Región Andina.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Preparado para: Taller de Reguladores: Asegurando Disponibilidad de Analgésicos Opioides para Cuidados Paliativos en Quito, Ecuador; Diciember de 2000. [Español]
• Joranson DE, Nischik JA, Gilson AM, Nelson JM, Maurer MA.  Consumption of opioid analgesics in the world and the Andean region.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the Regulators Meeting to Ensure the Availability of Opioid Analgesics for Palliative Care in Quito, Ecuador; December 2000. [English]
  
  Joranson DE, Ryan KM, Maurer MA.  Conference on monitoring and regulating schedule II controlled substances.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the meeting of the California Board of Pharmacy in Sacramento, California USA; February 2000.

• Joranson DE.  Availability of opioid analgesics in Asia: Progress, problems, recommendations.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the 14th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control in Tokyo, Japan; June 1999.
• Joranson DE.  Working with governments to improve the availability of opioid analgesics.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the 9th World Congress on Pain International Association for the Study of Pain in Vienna, Austria; August 1999.

• Joranson DE, Gilson AM, Monterroso M, Nelson JM. Opioid analgesics in Latin America: Legal requirements, trends, recommendations.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the 5th Latin American Congress of Palliative Care in Concepción, Chile; March 1998.

• Joranson DE, Gilson AM.  Opioid availability for selected countries in Asia and Latin America.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the 12th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control in Tokyo, Japan; June 1997.
• Joranson DE, Gilson AM. To what extent has the WHO Analgesic Ladder influenced morphine consumption in the world? A conceptual framework, review of consumption data, recommendations and resources. Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the Sertuerner Workshop in Einbeck, Germany; August 1997.
• Joranson DE, Gilson AM. Opioid availability: Diagnosis and treatment of regulatory barriers.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the International Conference on Comprehensive Cancer Care "Focus on Cancer Pain" in Limassol, Cyprus; May 1997.
• Joranson DE, Gilson AM. Availability of opiates and psychotropic drugs for medical purposes.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.  Prepared for the International Narcotics Control Board/Inter-American Commission on Drug Abuse in San Juan, Puerto Rico; December 1997.

• Joranson DE, DeLima L. Preliminary analysis of the Colombian legislation relating to the international principles of opioid availability.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.1996. (in Spanish)
• Joranson DE, DeLima L. Preliminary analysis of the Mexican legislation relating to the international principles of opioid availability.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA.1996. (in Spanish)
• Joranson DE, Smokowski PR, De Lima L. Tendencias en el consumo de opioids en Sur America.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA. Prepared for the Reunion de Coordinacion de Programes de Medicamentos para la Area Andina en Caracas, Venezuela; July 1996.
• Joranson DE, Smokowski PR.  Opioid consumption in Asia, defining "addiction", and steps to make opioids available for cancer pain relief. Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin, USA. Prepared for the Hospice Care in Asia International Conference in Singapore; February 1996.
• Joranson DE, Smokowski PR. Opioid consumption trends in Latin America.  Pain & Policy Studies Group/World Health Organization Collaborating Center for Policy and Communications in Cancer Care.  University of Wisconsin Comprehensive Cancer Center.  Madison, Wisconsin USA; 1996.

• Joranson DE, Smokowski, PR. Pain management and opioid regulation: Resources for progress. Pain Research Group/World Health Organization Collaborating Center for Symptom Evaluation.  University of Wisconsin Medical School.  Madison, Wisconsin, USA. Prepared for the 4th Congress of the European Association for Palliative Care in Barcelona, Spain; December 1995.

• Joranson DE, Gilson AM, Krchnavek K. Opioid analgesics for cancer pain relief: A review of consumption trends and the literature relating to Asian countries, Pain Research Group/World Health Organization Collaborating Center for Symptom Evaluation. University of Wisconsin Medical School.  Madison, Wisconsin, USA. Prepared for the 9th Study Programme for Overseas Experts on Drug Abuse and Narcotic Control in Tokyo, Japan; 1994.
• Joranson DE, Gilson AM, Krchnavek K. Opioid analgesics for cancer pain relief: A review of consumption trends and the literature relating to Latin American countries. Pain Research Group/World Health Organization Collaborating Center for Symptom Evaluation.  University of Wisconsin Medical School.  Madison, Wisconsin, USA. Prepared for III Congreso Latino Americano de Cuidados Paliativos e Dor Neoplasica; 1994.

Back to top of page

• Ryan, K. M., Joranson, D. E., and Gilson, A. M. Toward a more complete indicator of opioid consumption trends. Presented at the 7th International Conference on Pain & Chemical Dependency; New York, New York; 21-24 June 2007 (Poster). 2007. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Maurer, M. A., Gilson, A. M., and Joranson, D. E. How do state policies address pain and addiction? Presented at the 7th International Conference on Pain & Chemical Dependency; New York, New York; 21-24 June 2007 (Poster). 2007. Madison, Wisconsin, USA, University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care.
• Maurer MA, Gilson AM, Joranson DE, Ryan KM, Garthwaite JP. How Do State Policies Address Pain and Addiction? University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Presented at the 67th Annual Scientific Meeting of the College on Problems of Drug Dependence; Orlando, Florida; 18-23 June 2005 (Poster).
• Maurer MA, Gilson AM, Joranson DE, Ryan KM, Jorenby JP. Changes in State Pain Policies Related to the Use of Controlled Substances for Pain Management. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Presented at the 22nd Annual Scientific Meeting of the American Pain Society; Chicago, IL; 20-23 March 2003 (Poster).
• Jorenby JP, Maurer MA, Joranson DE. WHO Internet Resources: Pain Policy & Communications. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Presented at the International Association for the Study of Pain 10th World Congress on Pain; San Diego, California; August 17-22, 2002 (Poster).
• Joranson DE, Gilson AM, Nelson JM, Ryan KM. Trends in Global Availability of Opioid Analgesics. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Presented at the 9th World Congress on Pain, International Association for the Study of Pain; Vienna, Austria; August, 1999 (Poster).
• Joranson DE, Gilson AM, Williams CM, Monterroso M, Ryan KM. Unprecedented Changes in State Pain Policy. American Pain Society, 1997